Clinical Research Directory
Browse clinical research sites, groups, and studies.
Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma
Sponsor: Anhui Provincial Hospital
Summary
Chemoradiotherapy has been a standard modality for inoperable locally advance esophageal carcinoma. The goal of this randomized control study is to compare the feasibility, and survival benefits of whole-course immunonutrition combined with chemoradiotherapy±ICIs for local advanced patients with inoperable esophageal squamous cell carcinoma. The main questions it aims to answer are: • If the feasibility and safety of whole-course immunonutrition combined with chemoradiotherapy±ICIs is better. • If the survival benefits (1, 2 and 3-years progression free survival) of whole-course immunonutrition combined with chemoradiotherapy±ICIs is longer. The Experimental group will receive a combination immunonutrition of omega-3 fatty acids, and glutamine, whereas the control group will receive standard formula.
Official title: Anhui Provincial Hospita
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
70
Start Date
2023-07-01
Completion Date
2026-12-01
Last Updated
2023-12-26
Healthy Volunteers
No
Interventions
Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs
The Experimental group received a combination of omega-3 fatty acids, and glutamine, whereas the control group received standard formula.
Locations (1)
Anhui provincial hospital
Hefei, China